Hims & Hers (HIMS) insider continues modest share sales via Form 144

Rhea-AI Filing Summary

Hims & Hers Health, Inc. (HIMS) filed a Form 144 indicating that stockholder Soleil Boughton intends to sell 2,572 Class A shares through Fidelity Brokerage on or about 07/28/2025 on the NYSE. The proposed sale has an aggregate market value of $150,976.40, based on data supplied in the filing. Shares outstanding are listed at 215,453,899, so the contemplated sale represents roughly 0.0012 % of total Class A shares.

The shares to be sold were acquired via restricted-stock vesting on 06/15/2025 and are being sold for compensation purposes. The filer certifies possession of no undisclosed material adverse information.

Recent activity: Over the past three months, the same seller disposed of 22,871 shares across seven transactions, generating $1.18 million in gross proceeds. Transaction sizes ranged from 2,572 to 5,451 shares, signalling a pattern of periodic liquidations rather than a single block sale.

No other financial metrics, earnings data, or company-level events are disclosed in this notice.

Positive

• None.

Negative

• Continued insider selling over the past three months (22,871 shares, $1.18 M) may be viewed by some investors as a bearish signal, even though volumes are small.

Insights

Equity Analyst

TL;DR – Small insider sale (0.001 % float); continuation of modest selling trend; limited market impact.

The Form 144 covers 2,572 shares worth ≈$151k—immaterial versus the 215 M shares outstanding. Including prior 90-day activity, the insider has monetized 22,871 shares for $1.18 M. While steady sales can signal diversification or liquidity needs, the scale is negligible for valuation. There is no indication of undisclosed negative information, and no linkage to earnings or guidance. I view the filing as neutral for the stock.

Corporate Governance Specialist

TL;DR – Filing shows compliant disclosure; sales executed under Rule 144, no red flags on governance.

Rule 144 requires aggregation disclosure; the filer lists all recent trades, demonstrating regulatory adherence. The planned sale stems from vested restricted stock, typical for employee compensation. Absence of a 10b5-1 date suggests discretionary timing but still within permissible limits. Given the fractional percentage of shares and transparent reporting, I classify the governance impact as neutral and non-material.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2572	150976.40	215453899	07/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	06/15/2025	Restricted Stock Vesting	Issuer			2572	06/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	04/28/2025	3236	97694.84
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	05/12/2025	3235	181160.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	05/27/2025	3233	180627.71
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/16/2025	5451	309616.80
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	2572	153677.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/30/2025	2572	129886.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/14/2025	2572	122993.04

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many HIMS shares does the insider plan to sell under this Form 144?

The filing covers the proposed sale of 2,572 Class A shares.

What is the market value of the planned HIMS share sale?

The aggregate market value reported is $150,976.40.

What percentage of HIMS total shares does the planned sale represent?

Approximately 0.0012 % of the 215,453,899 shares outstanding.

Has the same insider sold HIMS shares recently?

Yes. Over the last three months the insider sold 22,871 shares across seven transactions, for $1.18 million in proceeds.

When were the shares to be sold originally acquired?

They were acquired via restricted-stock vesting on 06/15/2025.